<DOC>
	<DOC>NCT00212719</DOC>
	<brief_summary>The purpose of this study is to evaluate the efficacy and safety of ONO-5920 in patients with involutional osteoporosis.</brief_summary>
	<brief_title>Controlled Study of ONO-5920 in Patients With Involutional Osteoporosis in Japan</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Diphosphonates</mesh_term>
	<criteria>1. A diagnosis in accordance with Criteria for the Diagnosis of Primary Osteoporosis. 2. Other inclusion criteria as specified in the study protocol. 1. Patients having secondary osteoporosis or another condition that presents low bone mass. 2. Patients having findings that affect measurement of lumbar spinal bone mineral density by DXA 3. Patients that have been administered bisphosphonate derivatives. 4. Other exclusion criteria as specified in the study protocol.</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>ONO-5920, osteoporosis, bisphosphonate</keyword>
</DOC>